Showing results (101-110 of 127) with videos related to
Sort By:
Pageof 13
Biorxiv : the Preprint Server for Biology|July 3, 2026
Human CD8-iTreg are potent GVHD suppressors and tumoricidal effectors by release of Granzyme-K + Supramolecular Attack ParticlesJemma H Larson, Ewoud B Compeer, Phillip R Dougherty, et al.Blood|June 15, 2023
Higher abatacept exposure after transplant decreases acute GVHD risk without increasing adverse eventsTakuto Takahashi, Mahmoud Al-Kofahi, Mutaz Jaber, et al.The Journal of Clinical Investigation|September 30, 2025
Acetyl-CoA carboxylase 1 inhibition increases Treg metabolism and graft-versus-host disease treatment efficacy via mitochondrial fusionCameron McDonald-Hyman, Ethan G Aguilar, Ewoud B Compeer, et al.JCI Insight|July 14, 2026
CAR19 Tregs treat murine chronic Graft-Versus-Host Disease through immune suppression in absence of measurable B-cell cytolysisSujeong Jin, Michael C Zaiken, Cameron McDonald-Hyman, et al.Science Translational Medicine|January 14, 2021
Spatiotemporal single-cell profiling reveals that invasive and tissue-resident memory donor CD8+ T cells drive gastrointestinal acute graft-versus-host diseaseVictor Tkachev, James Kaminski, E Lake Potter, et al.Cell Reports Methods|April 29, 2025
Accurate prediction of absolute prokaryotic abundance from DNA concentrationJakob Wirbel, Tessa M Andermann, Erin F Brooks, et al.Transplantation and Cellular Therapy|August 30, 2021
Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium 2021: Looking Forward as the Network Celebrates its 20th YearHelen E Heslop, Edward A Stadtmauer, John E Levine, et al.Science Translational Medicine|June 28, 2023
Notch signaling drives intestinal graft-versus-host disease in mice and nonhuman primatesVictor Tkachev, Ashley Vanderbeck, Eric Perkey, et al.Medrxiv : the Preprint Server for Health Sciences|July 3, 2026
Local and circulating cytotoxic CD4⁺ T cells are early markers of disease activity in pediatric Crohn's diseaseVeronika Niederlova, Kyle Kimler, Hengqi Betty Zheng, et al.Blood|September 25, 2020
Repurposing a novel anti-cancer RXR agonist to attenuate murine acute GVHD and maintain graft-versus-leukemia responsesGovindarajan Thangavelu, Chao Wang, Michael Loschi, et al.Pageof 13